- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Conductus and Varian debut NMR probe
A new detector for NMR spectroscopy that uses high-temperaturesuperconducting technology has been introduced by Conductus ofSunnyvale, CA, and Varian Associates of Palo Alto, CA. The detector,SuperProton nmr, increases sensitivity by at least four
A new detector for NMR spectroscopy that uses high-temperature
superconducting technology has been introduced by Conductus of
Sunnyvale, CA, and Varian Associates of Palo Alto, CA. The detector,
SuperProton nmr, increases sensitivity by at least four times
over conventional probes, according to the companies. Conductus
is manufacturing the probes, which will be used with Varian's
NMR spectrometers such as the new Unity Inova line (SCAN 3/27/96).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
